BioMed Research International / 2009 / Article / Fig 6

Research Article

OXavidin for Tissue Targeting Biotinylated Therapeutics

Figure 6

Tissue residence of OXavidin/biotin complex. 125I-labeled avidin, avidin/ST2210, OXavidin, or OXavidin/ST2210 were injected in the limb of Balb/c mice. At the indicated time points after intramuscular injection mice were sacrificed and samples of treated limb weighted and counted in a gamma counter. Data are expressed as % ID/100 mg of tissue. Each point is the average of 5 mice. Bars represent standard deviation. Student’s test was used for statistical analysis. NS: Not significant.

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.